BERLIN, 30 October 2013 – During his official visit to Berlin today, LI Yong, the Director General of the United Nations Industrial Development Organization (UNIDO), was received by government officials, including Harald Braun, State Secretary of the Federal Foreign Office, and Dirk Niebel, Federal Minister for Economic Cooperation and Development (BMZ).
They voiced support for the work of the Organization and its focus on inclusive and sustainable industrial development.
Director General Li and Dirk Niebel signed an agreement under which the Government of Germany will continue funding a UNIDO project in support of local production of essential generic medicines in developing and least developed countries, including in Africa.
Currently, the project assists the local pharmaceutical production in Ghana, Kenya and Viet Nam. Advanced training on industrial pharmacy is supported in Tanzania as are early operations of two newly formed business associations, the Federation of Pharmaceutical Manufacturers Associations (FAPMA) and the Southern African Generics Medicines Association (SAGMA). The new funding will accelerate the implementation of the 2012 Business Plan of the African Union’s Pharmaceutical Manufacturing Plan for Africa (PMPA), a joint endeavor with the African Union Commission. It is envisaged that in the future the project could include further countries: Nigeria, Uganda, and Zimbabwe.
“Poor people around the world, including in Africa, should be able to have access to affordable, quality medication, and be shielded from the numerous counterfeit medicines that endanger lives. UNIDO is working to make this a reality,” said Director General Li.
Since 2006, Germany has contributed over EUR 100 million to the development of the African pharmaceutical industry and the production of essential medicines, and remains a trusted partner in UNIDO’s efforts to help promote local pharmaceutical production in Africa.
Director General Li also had meetings with representatives of the German Engineering Association (VDMA), the METRO Group, the GEA Group, KHS GmbH, FAWEMA GmbH, and Bosch GmbH.
For more information on UNIDO efforts to strengthen the local production of essential generic drugs in developing countries, please see
UNIDO Senior Industrial Development Officer